Reata Pharmaceuticals INC
SEC CIK 1358762 · RETA · last insider filing 2023-09-28
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Cpmg Inc | Director | filed 2016 - 2023 |
| Desai Antal Rohit | Director | filed 2023 - 2023 |
| Rose William | Director | filed 2016 - 2023 |
| Mcgaughy R Kent Jr | Director | filed 2016 - 2023 |
| Edwards Martin | Director | filed 2020 - 2023 |
| Huff James Warren | Director · See Remarks | filed 2016 - 2023 |
| Ruff Shamim | Director | filed 2021 - 2023 |
| Mcclellan William D. Jr. | Director | filed 2017 - 2023 |
| Oliger Christy J. | Director | filed 2021 - 2023 |
| Ryder Steven | Director | filed 2022 - 2023 |
| Nielsen Jack | Director | filed 2016 - 2021 |
| Bass James Edward | Director | filed 2016 - 2020 |
| Stone Dennis K. | Director | filed 2016 - 2016 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Wortley Michael D | See Remarks | filed 2016 - 2023 |
| Soni Manmeet Singh | Chief Financial Officer | filed 2019 - 2023 |
| Loewen Andrea | SVP, Global Regulatory Affairs | filed 2022 - 2023 |
| Patni Rajiv | EVP, Chief R&D Officer | filed 2023 - 2023 |
| Meyer Colin John | See Remarks | filed 2016 - 2023 |
| Bir Dawn Carter | VP, Chief Commercial Officer | filed 2016 - 2023 |
| Anand Bhaskar | VP, Chief Accounting Officer | filed 2021 - 2023 |
| Khan Samina | SVP, Chief Medical Officer | filed 2022 - 2023 |
| Castellanos Elaine | VP, Chief Accounting Officer | filed 2016 - 2021 |
| Wilson Jason Douglas | See Remarks | filed 2016 - 2020 |
| Ward Keith Wayne | See Remarks | filed 2016 - 2019 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.